TABLE OF CONTENTS

1. Cover
2. Title Page
3. Authorisation
4. Acknowledgements
5. About the company
6. Limitations
7. Conclusion
SUMMER INTERNSHIP PROGRAM – 2023

AN INTERIM REPORT

ON

FINANCE INTERN

SUBMITTED BY

Kolagatla Rohith Appi Reddy

22FMUCHH010368

Hetero Drugs (Unit 1 Bonthapally )

 A REPORT

ON

FINANCE INTERN

BY:- K. ROHITH APPI REDDY

22FMUCHH010368

Hetero Drugs (Unit 1 Bonthapally)

A report submitted in partial fulfilment of the requirements of BBA Program of

IBS Hyderabad

Distribution List: 04/07/2023

AUTHORISATION

This is to certify that the finance Report at Hetero Drugs (Unit 1 Bonthapally)
Hyderabad Submitted by K. ROHITH APPI REDDY bearing enrolment No.
22FMUCHH010368 in partial fulfilment of the requirement of BBA Program of IBS
Hyderabad is an original work and carried out under the supervision of DR N. AKBAR
JAN

IBS Hyderabad.

SUBMITTED TO

DR N. AKBAR JAN
(SIP MENTOR)
ACKNOWLEDGEMENT

 I would like to express my profound gratitude to all those who have been
helpful in the preparation of my project report. I would like to thank Hetero
Drugs (Unit 1 Bonthapally) for providing me the chance to undertake this
internship study and allowing me to explore the area of FINANCE and
giving me rich experiences and opportunities that I personally believe will
forever shape and influence my professional life while fostering personal
growth and development.

 I would like to thank MR G. YALAMANCHILI my company guide for his

invaluable supervision and guidance during the period. I am incredibly
grateful for their continuous support, advice and encouragement.

 I am deeply grateful to my faculty guide DR N. AKBAR JAN for his

invaluable suggestions, -comments, feedback, and support throughout the
internship. His patience and faith in my abilities always boosted my confidence.
ABOUT THE COMPANY

 Hetero Drugs (Unit 1 Bonthapally) Limited operates as a

pharmaceutical company. Hetero is one of India’s leading
generic pharmaceutical companies and is one of the world’s
largest producers of anti-retroviral drugs for the treatment of
HIV/AIDS. With more than 20 years of expertise in the
pharmaceutical industry. Hetero also offers custom
pharmaceutical services to its partners around the world. The
company, manufacturing, and commercialization of a wide
range of products.

 The company is recognized for its strengths in Research and

Development

.
 Hetero Drugs (Unit 1 Bonthapally) The current status of Hetero Drugs
Limited is - Active. The last reported AGM (Annual General Meeting) of
Hetero Drugs Limited, per our records, was held on 30 September, 2022.
Hetero Labs Limited (HLL) is a leading Public Limited Indian Non-
Government Company incorporated in India on 10 March 1989 and has a
history of 34 years and three months. Its registered office is in Rangareddy
DIST, Telangana, India.
LIMITATIONS:
Limitations are the one which are restricted with Limited rules and set of
guidelines or circumstances. In this study limitations are:

1.finance should have the report of the top-level management.

2. It lacks the universally approved academic base.

3. finance should be implemented by assessing the training and development

requirement of employees.
CONCLUSION
In this Interim Report, the focus is on the work experience I encountered during the
internship allowed me to develop skills.

I think I still require to work on my other skills too.

But the overall experience was positive and everything I learned would be useful in my
future career in this field.